National Health Investors (NHI) to Release Quarterly Earnings on Thursday

National Health Investors (NYSE:NHI) is expected to be announcing its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of $1.21 per share and revenue of $85.6550 million for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Friday, November 7, 2025 at 10:00 AM ET.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.06. The company had revenue of $70.27 million for the quarter, compared to analysts’ expectations of $86.46 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.18 earnings per share. On average, analysts expect National Health Investors to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

National Health Investors Price Performance

Shares of NHI stock opened at $74.92 on Wednesday. The stock has a market cap of $3.56 billion, a price-to-earnings ratio of 23.94, a PEG ratio of 3.31 and a beta of 0.77. The business’s fifty day moving average is $76.89 and its 200 day moving average is $74.34. National Health Investors has a twelve month low of $65.13 and a twelve month high of $82.32. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on NHI shares. Truist Financial upped their price target on National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a research note on Friday, August 15th. National Bankshares set a $90.00 price target on National Health Investors in a research note on Wednesday, October 1st. Wells Fargo & Company boosted their target price on National Health Investors from $76.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 27th. KeyCorp raised National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 target price on the stock in a report on Thursday, July 10th. Finally, Cantor Fitzgerald initiated coverage on National Health Investors in a report on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $84.83.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. EverSource Wealth Advisors LLC lifted its holdings in shares of National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares in the last quarter. NewEdge Advisors LLC lifted its holdings in shares of National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 345 shares in the last quarter. Osaic Holdings Inc. lifted its holdings in shares of National Health Investors by 24.1% during the second quarter. Osaic Holdings Inc. now owns 1,629 shares of the real estate investment trust’s stock valued at $115,000 after purchasing an additional 316 shares in the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of National Health Investors by 54.4% during the second quarter. BNP Paribas Financial Markets now owns 4,334 shares of the real estate investment trust’s stock valued at $304,000 after purchasing an additional 1,527 shares in the last quarter. Finally, Cetera Investment Advisers lifted its holdings in shares of National Health Investors by 6.1% during the second quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock valued at $336,000 after purchasing an additional 275 shares in the last quarter. 62.51% of the stock is owned by institutional investors.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.